Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway targetgenes and promote cell migration

Por Haskins, Jonathan W., Nguyen, Don X., Stern, David F.
Publicado no Sci Signal (2014)

Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells

Por Wali, Vikram B., Haskins, Jonathan W., Gilmore-Hebert, Maureen, Platt, James T., Liu, Zongzhi, Stern, David F.
Publicado no Mol Cancer Res (2014)

EGF Receptor activates MET through MAP kinases to enhance non-small cell lung carcinoma invasion and brain metastasis

Por Breindel, Jerrica L., Haskins, Jonathan W., Cowell, Elizabeth P., Zhao, Minghui, Nguyen, Don X., Stern, David F.
Publicado em 2013

Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis

Por Wali, Vikram B, Gilmore-Hebert, Maureen, Mamillapalli, Ramanaiah, Haskins, Jonathan W, Kurppa, Kari J, Elenius, Klaus, Booth, Carmen J, Stern, David F
Publicado no Breast Cancer Res (2014)

Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake

Por Haskins, Jonathan W., Zhang, Shannon, Means, Robert E., Kelleher, Joanne K., Cline, Gary W., Canfrán-Duque, Alberto, Suárez, Yajaira, Stern, David F.
Publicado no Sci Signal (2015)